Literature DB >> 3954941

The warfarin-cimetidine interaction: stereochemical considerations.

S Toon, K J Hopkins, F M Garstang, B Diquet, T S Gill, M Rowland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954941      PMCID: PMC1400926          DOI: 10.1111/j.1365-2125.1986.tb05186.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Cimetidine interaction with warfarin.

Authors:  D Hetzel; D Birkett; J Miners
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

2.  Comparative pharmacokinetics of coumarin anticoagulants. V. Kinetics of warfarin elimination in the rat, dog, and rhesus monkey compared to man.

Authors:  R Nagashima; G Levy
Journal:  J Pharm Sci       Date:  1969-07       Impact factor: 3.534

3.  Cimetidine increases the action of warfarin in man [proceedings].

Authors:  A M Breckenridge; M Challiner; S Mossman; B K Park; M J Serlin; R G Sibeon; J R Williams; J M Willoughby
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

Review 4.  Cimetidine as an inhibitor of drug metabolism: therapeutic implications and review of the literature.

Authors:  J H Bauman; B J Kimelblatt
Journal:  Drug Intell Clin Pharm       Date:  1982-05

5.  Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.

Authors:  R A O'Reilly
Journal:  Arch Intern Med       Date:  1984-05

6.  Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.

Authors:  C Banfield; R O'Reilly; E Chan; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

7.  Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine.

Authors:  C Banfield; M Rowland
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

  7 in total
  11 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

2.  Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9.

Authors:  Kerenaftali Klein; Ivelina Gueorguieva; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-21       Impact factor: 2.745

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.

Authors:  W M Awni; Z Hussein; G R Granneman; K J Patterson; L M Dubé; J H Cavanaugh
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

5.  Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin.

Authors:  Jasper Dingemanse; Carsten Meyerhoff; Jan Schadrack
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

Review 6.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 8.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

9.  Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen.

Authors:  A M Evans; R L Nation; L N Sansom
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 10.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.